FindTrial
Sign In

Multimodal imaging study of immune checkpoint inhibitor associated myocarditis

Multimodal imaging study of immune checkpoint inhibitor associated myocarditis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200056629
Enrollment
Unknown
Registered
2022-02-09
Start date
2022-02-28
Completion date
Unknown
Last updated
2023-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Immune associated myocarditis

Interventions

NA:NA

Sponsors

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age = 18 years old; 2. Patients with clinically suspected ICIs-related myocarditis were continuously included; 3. The patient or family member can understand the research protocol and is willing to participate in the study, and provide written informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with claustrophobia; 2. Patients with metal foreign bodies in the body; 3. Patients with gadolinium contrast agent allergy; 4. Patients who can not cooperate to complete various imaging examinations; 5. Patients or family members cannot understand the conditions and objectives of this study.

Design outcomes

Primary

MeasureTime frame
major adverse cardiovascular events;—

Countries

China

Contacts

Public ContactWang Yining

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences

973350100@qq.com+86 13661003076

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026